Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
Bristol-Myers Squibb
University Medical Centre Maribor
Fudan University
Regeneron Pharmaceuticals
Hunan Province Tumor Hospital
Celldex Therapeutics
Swiss Cancer Institute
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Intergroupe Francophone de Cancerologie Thoracique
Transgene
Spectrum Pharmaceuticals, Inc
Intergroupe Francophone de Cancerologie Thoracique
European Lung Cancer Working Party
Yonsei University
Roswell Park Cancer Institute
Finnish Lung Cancer Group
Merck KGaA, Darmstadt, Germany
Alliance for Clinical Trials in Oncology
North China Petroleum Bureau General Hospital
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Pfizer
Hoffmann-La Roche
University of Alabama at Birmingham
Clinical Oncology Research Associates
Clinical Oncology Research Associates
International Atomic Energy Agency
National Cancer Institute (NCI)
Maastricht Radiation Oncology
Roswell Park Cancer Institute
Pfizer
Memorial Sloan Kettering Cancer Center